Patent holdings for IPC class A61K 9/16

Total number of patents in this class: 11078

10-year publication summary

901
790
892
885
955
906
797
750
652
425
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Novartis AG
10178
89
The Regents of the University of California
20802
85
Board of Regents, The University of Texas System
6135
67
BASF SE
21310
66
MannKind Corporation
555
61
Inventage Lab, Inc.
99
58
The Johns Hopkins University
5907
56
DSM IP Assets B.V.
5385
52
Vertex Pharmaceuticals Incorporated
1579
42
Crititech, Inc.
74
42
Evonik Operations GmbH
4380
42
Massachusetts Institute of Technology
10273
38
ratiopharm GmbH
292
38
Knoa Pharma LLC, Purdue Pharma, Inc., Corporation, Delaware
85
38
Merck Patent GmbH
5735
37
Takeda Pharmaceutical Company Limited
2712
35
Flamel Ireland Limited
120
35
Purdue Pharma L.P.
448
35
G2gbio, Inc.
45
35
Boehringer Ingelheim International GmbH
4483
33
Other owners 10094